An open label randomized multicentre phase IIIb trial comparing parenteral substitution versus best supportive nutritional care in subjects with pancreatic adenocarcinoma receiving 5-FU plus oxaliplatin as 2ndor higher line chemotherapy regarding clinical benefit - PANUSCO

Peer Review reports

Original Submission
2 Oct 2009	Submitted	Original manuscript
Resubmission - Version 2
	Submitted	Manuscript version 2
18 Nov 2009	Author responded	Author comments - Moritz N Wente
Resubmission - Version 3
18 Nov 2009	Submitted	Manuscript version 3
Publishing
27 Nov 2009	Editorially accepted
27 Nov 2009	Article published	10.1186/1471-2407-9-412

Back to article page